Showing 3851-3860 of 7016 results for "".
CDC - Lyme Disease: Challenges and Innovations, Part 1
https://reachmd.com/programs/grand-rounds-nation/cdc-lyme-disease-challenges-and-innovations-part-1/6483/Lyme disease is one of the most rapidly emerging infectious diseases in North America and Europe. In 2009, nearly 30,000 confirmed and more than 8,500 probable cases of Lyme disease were reported to the CDC in the United States alone. Named after a small Connecticut town, Lyme disease is transmittedCDC - Sodium Reduction: Time for Choice, Part 2
https://reachmd.com/programs/grand-rounds-nation/cdc-sodium-reduction-time-for-choice-part-2/6438/The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, butCDC - Sodium Reduction: Time for Choice, Part 1
https://reachmd.com/programs/grand-rounds-nation/cdc-sodium-reduction-time-for-choice-part-1/6437/The vast majority of US adults consume more than double the recommended maximum of sodium, which is a direct cause of hypertension, a condition that affects nearly 1 in 3 Americans. Hypertension is not only a major contributor to cardiovascular disease (CVD), disability, and health disparities, but- CDC Reports Interim 2025-26 Influenza Vaccine Effectivenesshttps://reachmd.com/news/cdc-reports-interim-2025-26-influenza-vaccine-effectiveness/2486778/Key Takeaways Vaccination was associated with reduced risk for influenza-associated outpatient visits and hospitalization, with higher overall estimates in children and adolescents than in adults. Reported protection included influenza A(H3N2) and infl
- Interim Estimates of 2025-26 Seasonal Influenza Vaccine Effectivenesshttps://reachmd.com/news/interim-estimates-of-2025-26-seasonal-influenza-vaccine-effectiveness/2486668/Key Takeaways In interim estimates, vaccine effectiveness against influenza-associated outpatient visits was 38%–41% in children and adolescents and 22%–34% in adults; effectiveness against influenza-associated hospitalization was 41% and 30%, respectively.
- CHMP Issues Positive Opinion for Redemplo in Adult FCShttps://reachmd.com/news/chmp-issues-positive-opinion-for-redemplo-in-adult-fcs/2486870/Key Takeaways The CHMP adopted a positive opinion recommending REDEMPLO for adults with familial chylomicronemia syndrome as an adjunct to diet to reduce triglyceride levels. In PALISADE, lower triglycerides and fewer acute pancreatitis cases were repo
- Pediatric Vaccination Strategies: Navigating SARS-CoV-2 Variant Challenges for 2025–26https://reachmd.com/news/pediatric-vaccination-strategies-navigating-sars-cov-2-variant-challenges-for-202526/2474968/As SARS-CoV-2 continues to evolve, pediatric vaccination strategies face underrecognized challenges that will shape the 2025–26 immunization landscape. The FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) conv
- Plozasiran In FCS: PALISADE Phase 3 And 1-Year Extensionhttps://reachmd.com/news/plozasiran-in-fcs-palisade-phase-3-and-1-year-extension/2486871/Key Takeaways Plozasiran was associated with durable triglyceride lowering through month 24, with similar levels in participants treated during the blinded phase and those who later crossed over from placebo. ApoC3 fell substantially, and some particip
- Extreme Heat Associated with Children's Asthma Hospital Visitshttps://reachmd.com/news/extreme-heat-associated-with-childrens-asthma-hospital-visits/2463112/Extreme heat associated with increased asthma hospital visits. Credit: ATS For children seeking care at a California
- NephCure Announces First-Ever IgA Nephropathy (IgAN) Awareness Day on September 26, 2024https://reachmd.com/news/nephcure-announces-first-ever-iga-nephropathy-igan-awareness-day-on-september-26-2024/2468134/PHILADELPHIA, Sept. 3, 2024 /PRNewswire/ -- NephCure, a leading nonprofit organization dedicated to finding better treatments and a cure for rare kidney disease, is proud to announce the inaugural IgA Nephropathy (IgAN) Awareness Day on September 26, 2024. The event is specifically dedicated to r